Topics

Donor-Derived iPS Cells Show Promise for Treating Eye Disease

16:51 EDT 30 Apr 2019 | Bioethics.com

(The Scientist) – The results of the first clinical trial using induced pluripotent stem cells from donors point to signs of efficacy for treating the progressive form of blindness known as age-related macular degeneration. Last week, the Japanese team of … Read More

Original Article: Donor-Derived iPS Cells Show Promise for Treating Eye Disease

NEXT ARTICLE

More From BioPortfolio on "Donor-Derived iPS Cells Show Promise for Treating Eye Disease"

Quick Search

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Stem Cells
Track and monitor developments in stem cell research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on stem cells and follow companies active in the stem cell industry.  BioPort...

Ophthalmology
Ophthalmology is the branch of medicine that is devoted to the study and treatment of eye diseases. As well as mild visual defects correctable by lenses, ophthalmology is concerned with glaucoma, uveitis and other serious conditions affecting the eye, ...